title: Cost-effectiveness of screening for and treating albuminuria in individuals without diabetes or hypertension: are we moving beyond the evidence?
authors.forename: Filippo
authors.initials: F
authors.lastname: Mangione
authors.forename: Ciro
authors.initials: C
authors.lastname: Esposito
authors.forename: Antonio
authors.initials: A
authors.lastname: Dal Canton
mesh_terms: D000419:Albuminuria / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000191:economics*; D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000175:diagnosis; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis; D007676:Kidney Failure, Chronic / Q000517:prevention & control*; D008297:Male; D008403:Mass Screening / Q000191:economics*; D012720:Severity of Illness Index
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors